Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GLA | P06280 | 2/20 | 0.58 |
| ▸ | CA12 | O43570 | 1/20 | 0.58 |
| ▸ | CA1 | P00915 | 1/20 | 0.58 |
| ▸ | CA2 | P00918 | 1/20 | 0.58 |
| ▸ | CA3 | P07451 | 1/20 | 0.58 |
| ▸ | CA4 | P22748 | 1/20 | 0.58 |
| ▸ | CA9 | Q16790 | 1/20 | 0.58 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.58 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.58 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.45 |
| ▸ | OPRM1 | P35372 | 3/20 | 0.45 |
| ▸ | DRD3 | P35462 | 3/20 | 0.45 |
| ▸ | CHRM2 | P08172 | 2/20 | 0.45 |
| ▸ | CHRM1 | P11229 | 2/20 | 0.45 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.45 |
| ▸ | HTR1A | P08908 | 1/20 | 0.45 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.45 |
| ▸ | DRD1 | P21728 | 1/20 | 0.45 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.45 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Phenol SCHEMBL11173099 | 1.00 | GLA (0.58) | GLACA12CA1CA2CA3 | |
| Phenol SCHEMBL10693914 | 0.97 | GLA (0.55) | GLACA12CA1CA2CA3 | |
| Phenol SCHEMBL28128844 | 0.97 | GLA (0.55) | GLACA12CA1CA2CA3 | |
| Toluene SCHEMBL18186092 | 0.91 | ACHE (0.48) | GLACA12CA1CA2CA3 | |
| Phenol SCHEMBL964056 | 0.89 | ESR1 (0.50) | GLACA12CA1CA2CA3 | |
| Phenol SCHEMBL964058 | 0.89 | ESR1 (0.50) | GLACA12CA1CA2CA3 | |
| Phenol SCHEMBL29096006 | 0.84 | BCHE (0.55) | ALDH1A1OPRM1DRD3CHRM2CHRM1 | |
| Phenol SCHEMBL3487571 | 0.84 | CA12 (0.41) | GLACA12CA1CA2CA3 | |
| Phenol SCHEMBL27850714 | 0.83 | CA12 (0.65) | GLACA12CA1CA2CA3 | |
| Phenol SCHEMBL1885111 | 0.83 | CA12 (0.73) | GLACA12CA1CA2CA3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 42 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115212921-B | Mixtures of bisphosphites having open and closed outer wing structural units and use thereof | 赢创奥克森诺有限责任两合公司 | 2024-07-12 | — | — | CN | disclosed |
| EP-4074721-B1 | DIPHOSPHITES HAVING ONE OPEN AND ONE CLOSED 2,4-METHYLATED BUILDING BLOCK | EVONIK OPERATIONS GMBH (DE) | 2023-10-04 | — | — | EP | disclosed |
| US-11739108-B2 | Diphosphites having an open, 2,4-methylated outer unit | EVONIK OPERATIONS GMBH (DE) | 2023-08-29 | — | — | US | disclosed |
| EP-4074720-B1 | MIXTURE OF BISPHOSPHITES WITH AN OPEN AND A CLOSED VOLATILE BUILDING BLOCK AND ITS USE AS CATALYST MIXTURE IN HYDROFORMYLATION | EVONIK OPERATIONS GMBH (DE) | 2023-07-19 | — | — | EP | disclosed |
| US-11618760-B2 | Diphosphites with an open, 3-methylated outer unit | EVONIK OPERATIONS GMBH (DE) | 2023-04-04 | — | — | US | disclosed |
| US-11565991-B2 | Mixture of bisphosphites having an open and a closed outer unit and the use thereof as a catalyst mixture in hydroformylation | EVONIK OPERATIONS GMBH (DE) | 2023-01-31 | — | — | US | disclosed |
| US-11560396-B2 | Diphosphites having an open and a closed 2,4-methylated outer unit | EVONIK OPERATIONS GMBH (DE) | 2023-01-24 | — | — | US | disclosed |
| US-20220340511-A1 | MIXTURE OF BISPHOSPHITES HAVING AN OPEN AND A CLOSED OUTER UNIT AND THE USE THEREOF AS A CATALYST MIXTURE IN HYDRFORMYLATION | EVONIK OPERATIONS GMBH (DE) | 2022-10-27 | — | — | US | disclosed |
| CN-115215904-A | Diphosphites having an open 3-methylated exo-wing building block | 赢创运营有限公司 | 2022-10-21 | — | — | CN | disclosed |
| CN-115212921-A | Mixture of bisphosphites having open and closed outer wing structural units and use thereof | 赢创运营有限公司 | 2022-10-21 | — | — | CN | disclosed |
| WO-1994006808-A1 | METHODS FOR THE SYNTHESIS OF PHOSPHONATE ESTERS | AFFYMAX TECHNOLOGIES N.V. (AN) | 1994-03-31 | — | — | WO | disclosed |
| EP-0351592-B1 | Low phosgene method for preparing aromatic bischloroformates | GEN ELECTRIC (US) | 1994-01-05 | — | — | EP | disclosed |
| US-5011966-A | Reacting dihydroxyaromatic compound, phosgene, waer, alkali or alkaline earth metal base; controlling phosgene concentration | GENERAL ELECTRIC COMPANY (US) | 1991-04-30 | — | — | US | disclosed |
| EP-0246825-B1 | QUATERNARY SALT SOLUTION ELECTROLYTE FOR ELECTROLYTIC CAPACITORS | MITSUBISHI PETROCHEMICAL CO., LTD. (JP) | 1991-02-27 | — | — | EP | disclosed |
| US-4774011-A | Electrolyte for aluminum electrolytic capacitor | MITSUBISHI PETROCHEMICAL CO., LTD. (JP) | 1988-09-27 | — | — | US | disclosed |
| EP-0246825-A2 | Quaternary salt solution electrolyte for electrolytic capacitors | MITSUBISHI PETROCHEMICAL CO., LTD. (JP) | 1987-11-25 | — | — | EP | disclosed |
| US-4225723-A | Process for the preparation of substituted arylcyanoalkyl and diaryl cyanoalkylimidazoles | ROHM AND HAAS COMPANY (US) | 1980-09-30 | — | — | US | disclosed |
| US-3979341-A | FLAME RETARDANT, INTUMESCENT | BORDEN PRODUCTS LIMITED (CA) | 1976-09-07 | — | — | US | disclosed |
| US-3966775-A | OXIDATION OF A 5-NITRO-1,4,4A,9A-TETRAHYDROQUINONE | NIPPON SHOKUBAI KAGAKU KOGYO CO., LTD. (JA) | 1976-06-29 | — | — | US | disclosed |
| US-3959344-A | POLYMERIZATION OF HYDROGEN CYANIDE IN A NITRILE SOLVENT | NIPPON CHEMICALS CO., LTD. (JA) | 1976-05-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11618760-B2 | Diphosphites with an open, 3-methylated outer unit | DPM1, DCTPP1, NUDT1 | GLA 3296/4885CA12 1482/4885CA1 3166/4885 |
| US-11560396-B2 | Diphosphites having an open and a closed 2,4-methylated outer unit | NUDT1, DCTPP1, DPM1 | GLA 3482/4885CA12 1438/4885CA1 2809/4885 |
| US-20220340511-A1 | MIXTURE OF BISPHOSPHITES HAVING AN OPEN AND A CLOSED OUTER UNIT AND THE USE THEREOF AS A CATALYST MIXTURE IN HYDRFORMYLATION | BPGM, FBP1, NUDT1 | GLA 2411/4885CA12 823/4885CA1 1603/4885 |
| US-11565991-B2 | Mixture of bisphosphites having an open and a closed outer unit and the use thereof as a catalyst mixture in hydroformylation | BPGM, NUDT1, PFKFB4 | GLA 2484/4885CA12 775/4885CA1 1620/4885 |
| US-11739108-B2 | Diphosphites having an open, 2,4-methylated outer unit | NUDT1, DCTPP1, DPM1 | GLA 3572/4885CA12 1256/4885CA1 2711/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.